CT | NG | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Sample type (n) | Females (287) | Males (98) | MSM Urine (56) | MSM Rectal (67) | MSM Pharynx (71) | Females (291) | Males (98) | MSM Urine (57) | MSM Rectal (67) | MSM Pharynx (72) |
Sensitivity% (95% CIa) | 100 (85.7–100b) | 100 (83.2–100b) | 66.7 (9.4–99.2) | 21.9 (14.7–94.7) | 50.0 (1.3–98.7) | 80.0 (28.4–99.5) | 83.3 (35.9–99.6) | 50.0 (18.7–81.3) | 78.9 (54.4–93.9) | 64.7 (38.3–85.8) |
Specificity% (95% CIa) | 99.6 (97.8–100.0) | 97.4 (90.9–99.7) | 98.1 (89.9–100) | 96.8 (88.8–99.6) | 100 (94.4–100b) | 99.6 (98.0–100.0) | 100 (96.1–100b) | 100 (92.3–100b) | 83.3 (69.8–92.5) | 96.4 (87.5–99.6) |
PPV (97.5% CIa) | 96.0 (79.6–99.9) | 91.3 (71.9–98.9) | 66.7 (9.4–99.2) | 21.9 (14.8–94.7) | 100 (2.5–100b) | 80 (28.4–99.5) | 100 (47.8–100b) | 100 (47.8–100b) | 65.2 (42.7–83.6) | 84.6 (54.6–98.1) |
NPV (95% CIa) | 100 (98.6–100b) | 100 (95.2–100b) | 98.1 (89.9–100) | 96.8 (88.8–99.6) | 97.2 (90.2–99.7) | 99.6 (98.0–100.0) | 98.9 (94.1–100) | 90.2 (78.6–96.7) | 90.9 (78.3–97.5) | 89.8 (79.2–96.2) |